Skip to Content

Internet-Delivered CBT Reduces Atopic Dermatitis Symptoms

WEDNESDAY, May 19, 2021 -- Internet-delivered cognitive behavior therapy (CBT) reduces symptoms of atopic dermatitis, according to a study published online May 19 in JAMA Dermatology.

Erik Hedman-Lagerlöf, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues randomly assigned adults with atopic dermatitis to either 12 weeks of therapist-guided internet-delivered CBT or a control condition that gave instructions regarding standard care in a 1:1 ratio (51 participants in each group).

The researchers found that participants receiving internet-delivered CBT had a significantly larger mean weekly reduction in symptoms of atopic dermatitis relative to controls, as measured with the Patient-Oriented Eczema Measure (ß = 0.32; 95 percent confidence interval, 0.14 to 0.49; P < 0.001) and with a moderate-to-large, controlled effect size after treatment (d = 0.75; 95 percent confidence interval, 0.32 to 1.16). Internet-delivered CBT also produced significantly larger reductions in itch intensity, perceived stress, sleep problems, and depression in secondary analyses. At 12-month follow-up, gains were sustained. Treatment satisfaction was high; therapists spent a mean of 39.7 minutes providing internet-delivered CBT per treated patient.

"This treatment can yield substantial improvements in atopic dermatitis symptoms, perceived stress, sleep problems, and depressive symptoms while requiring minimal therapist resources," the authors write.

One author disclosed financial ties to DahliaQomit; the author also has a patent for a CBT manual for irritable bowel syndrome, with royalties paid from Pear Therapeutics.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Upadacitinib Treats Moderate-to-Severe Atopic Dermatitis

FRIDAY, May 21, 2021 -- Upadacitinib shows short-term efficacy for moderate-to-severe atopic dermatitis in adolescents and adults, according to a study published online May 20 in...

Baricitinib Shows Long-Term Efficacy for Atopic Dermatitis

THURSDAY, May 13, 2021 – Baricitinib demonstrates sustained long-term efficacy in patients with moderate-to-severe atopic dermatitis, according to a study published online...

Hand Dermatitis Currently Prevalent in Health Care Workers

WEDNESDAY, May 12, 2021 -- More than 90 percent of health care workers and two-thirds of the general population currently have hand dermatitis, according to a study presented at...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.